register

News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices and techniques. Gosford Private Hospital in New South Wales achieved a notable milestone by successfully performing Australia’s first procedure using the Boston Scientific Avvigo+ system, led by interventional cardiologists Associate Professor Tom Ford and Dr Prajith Jeyaprakash.

The introduction of intracoronary imaging (ICI) has dramatically improved understanding of the mechanical and technical factors that contribute to both successful and failed PCI, becoming essential in complex transcatheter interventions.

Recognising the importance of intracoronary imaging, the American College of Cardiology Committee on Clinical Practice Guidelines recommended its routine use in PCI procedures last year.

The Avvigo+ system is the first intravascular ultrasound (IVUS) imaging system equipped with artificial intelligence (AI) software, known as Automated Lesion Assessment. This innovative technology automates key procedural steps, provides precise vessel measurements, and reduces procedure time by acquiring IVUS images at a faster speed. Additionally, it offers enhanced guidance by generating a physiology graph, effectively creating a roadmap to treat diseased coronary arteries.

Pat Callanan, Business Unit Director ANZ, Interventional Cardiology at Boston Scientific, said “The Avvigo+ Multi-Modality Guidance System aims to give cardiac cath labs more options in the space of imaging and physiology. Advancements in healthcare technology and treatments are crucial for improving patient outcomes and enhancing the quality of care.”

In a global collaboration with Boston Scientific, GE HealthCare is positioning its Allia IGS Pulse at the centre of the cath lab, making it compatible with various hardware from device developers, including the Avvigo+.

The company’s AutoRight Plus AI-powered software will work with the Avvigo+ system’s automated lesion assessment capabilities. It uses intravascular ultrasound imaging catheters and machine learning algorithms to automatically identify blood vessel borders and diameters for precise stent placements.

The Avvigo+ system is not currently approved on the Australian Register of Therapeutic Goods (ARTG).

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.